{
    "accessibility": "Open access",
    "additionDate": "2021-12-16T00:05:29.362566Z",
    "biotoolsCURIE": "biotools:pipo",
    "biotoolsID": "pipo",
    "confidence_flag": "tool",
    "cost": "Free of charge",
    "credit": [
        {
            "email": "egarralda@vhio.net",
            "name": "Elena Garralda"
        },
        {
            "email": "imatos@vhio.net",
            "name": "Ignacio Matos",
            "orcidid": "https://orcid.org/0000-0002-6396-630X"
        },
        {
            "name": "Guillermo Villacampa"
        },
        {
            "name": "Maria Vieito",
            "orcidid": "https://orcid.org/0000-0001-7531-343X"
        },
        {
            "name": "Omar Saavedra",
            "orcidid": "https://orcid.org/0000-0003-4160-791X"
        }
    ],
    "description": "A web tool to improve patient selection for oncology early phase clinical trials.",
    "editPermission": {
        "type": "private"
    },
    "function": [
        {
            "operation": [
                {
                    "term": "Phasing",
                    "uri": "http://edamontology.org/operation_3454"
                },
                {
                    "term": "Splitting",
                    "uri": "http://edamontology.org/operation_3359"
                },
                {
                    "term": "Validation",
                    "uri": "http://edamontology.org/operation_2428"
                }
            ]
        }
    ],
    "homepage": "https://pipo.vhio.net/",
    "lastUpdate": "2021-12-16T00:05:29.366525Z",
    "license": "Not licensed",
    "name": "PIPO",
    "operatingSystem": [
        "Linux",
        "Mac",
        "Windows"
    ],
    "owner": "Jennifer",
    "publication": [
        {
            "doi": "10.1016/J.EJCA.2021.05.040",
            "metadata": {
                "abstract": "© 2021 The AuthorsPurpose: Patient selection in phase 1 clinical trials (Ph1t) continues to be a challenge. The aim of this study was to develop a user-friendly prognostic calculator for predicting overall survival (OS) outcomes in patients to be included in Ph1t with immune checkpoint inhibitors (ICIs) or targeted agents (TAs) based on clinical parameters assessed at baseline. Methods: Using a training cohort with consecutive patients from the VHIO phase 1 unit, we constructed a prognostic model to predict median OS (mOS) as a primary endpoint and 3-month (3m) OS rate as a secondary endpoint. The model was validated in an internal cohort after temporal data splitting and represented as a web application. Results: We recruited 799 patients (training and validation sets, 558 and 241, respectively). Median follow-up was 21.2 months (m), mOS was 10.2 m (95% CI, 9.3–12.7) for ICIs cohort and 7.7 m (95% CI, 6.6–8.6) for TAs cohort. In the multivariable analysis, six prognostic variables were independently associated with OS – ECOG, number of metastatic sites, presence of liver metastases, derived neutrophils/(leukocytes minus neutrophils) ratio [dNLR], albumin and lactate dehydrogenase (LDH) levels. The phase 1 prognostic online (PIPO) calculator showed adequate discrimination and calibration performance for OS, with C-statistics of 0.71 (95% CI 0.64–0.78) in the validation set. The overall accuracy of the model for 3m OS prediction was 87.2% (95% CI 85%–90%). Conclusions: PIPO is a user-friendly objective and interactive tool to calculate specific survival probabilities for each patient before enrolment in a Ph1t. The tool is available at https://pipo.vhio.net/.",
                "authors": [
                    {
                        "name": "Alonso G."
                    },
                    {
                        "name": "Azaro A."
                    },
                    {
                        "name": "Berche R."
                    },
                    {
                        "name": "Brana I."
                    },
                    {
                        "name": "Carles J."
                    },
                    {
                        "name": "Dienstmann R."
                    },
                    {
                        "name": "Elez E."
                    },
                    {
                        "name": "Felip E."
                    },
                    {
                        "name": "Galvao V."
                    },
                    {
                        "name": "Gardeazabal I."
                    },
                    {
                        "name": "Garralda E."
                    },
                    {
                        "name": "Hernando-Calvo A."
                    },
                    {
                        "name": "Hierro C."
                    },
                    {
                        "name": "Macarulla T."
                    },
                    {
                        "name": "Martin-Liberal J."
                    },
                    {
                        "name": "Matos I."
                    },
                    {
                        "name": "Munoz-Couselo E."
                    },
                    {
                        "name": "Oaknin A."
                    },
                    {
                        "name": "Ochoa de Olza M."
                    },
                    {
                        "name": "Pedrola A."
                    },
                    {
                        "name": "Rodon J."
                    },
                    {
                        "name": "Ros J."
                    },
                    {
                        "name": "Saavedra O."
                    },
                    {
                        "name": "Saura C."
                    },
                    {
                        "name": "Tabernero J."
                    },
                    {
                        "name": "Viaplana C."
                    },
                    {
                        "name": "Vieito M."
                    },
                    {
                        "name": "Villacampa G."
                    }
                ],
                "date": "2021-09-01T00:00:00Z",
                "journal": "European Journal of Cancer",
                "title": "Phase I prognostic online (PIPO): A web tool to improve patient selection for oncology early phase clinical trials"
            },
            "pmid": "34385069"
        }
    ],
    "toolType": [
        "Web application"
    ],
    "topic": [
        {
            "term": "Oncology",
            "uri": "http://edamontology.org/topic_2640"
        },
        {
            "term": "Preclinical and clinical studies",
            "uri": "http://edamontology.org/topic_3379"
        },
        {
            "term": "Statistics and probability",
            "uri": "http://edamontology.org/topic_2269"
        }
    ],
    "validated": 1
}
